Michael Wang

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  

Michael Wang
Oct 1, 2024, 18:00 | Insight
Michael Wang: Drug tolerant persister cell plasticity in cancer
Michael Wang shared a post on X about a recent paper by Jun He et…
Aug 14, 2024, 14:08 | Insight
Michael Wang: Phenotype- and target-driven discovery are necessary for finding cures
Michael Wang shared on X a recent paper by Zhenyi Wang et al. titled "Innovating…
Aug 12, 2024, 01:20 | Blog
Using CRISPR technology to enhance CAR-T cells
Patrick Hwu shared on X: "How do we make more effective CAR-T cells? The Marco Ruella…
Jul 21, 2024, 12:19 | Blog
Oncoinfluencers to Follow on Social Media: Dr. Michael Wang
At OncoDaily, we are excited to highlight Dr. Michael Wang, a prominent researcher and clinician…
Jul 17, 2024, 05:10 | Insight
The ideal combination partner for BiTE therapy
Michael Wang, Professor in the Department of Lymphoma/Myeloma and the Department of Stem Cell Transplantation and…
Jul 13, 2024, 21:06 | Insight
Michael Wang: CDK9 is a promising target in MCL
Michael Wang, Professor in the Department of Lymphoma/Myeloma and the Department of Stem Cell Transplantation…
Jul 1, 2024, 02:17 | Opinion
Michael Wang: Excellent review of the actions and complex regulation of p53
Michael Wang, Professor in the Department of Lymphoma/Myeloma and the Department of Stem Cell Transplantation…
Jun 29, 2024, 16:57 | Insight
MD Anderson Research Highlights: EHA 2024 Special Edition
The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in…
Jun 20, 2024, 10:10 | Insight
Date of improved response rates in mantle cell lymphoma patients
MD Anderson Cancer Center shared on LinkedIn: "Adding the BTK inhibitor acalabrutinib to chemoimmunotherapy shows…
Jun 19, 2024, 22:16 | Blog
Michael Wang: An international randomized phase 3 trial is a huge undertaking
Michael Wang, Professor in the Department of Lymphoma/Myeloma and the Department of Stem Cell Transplantation and…
Jun 17, 2024, 17:03 | Blog
Michael Wang: I presented the data from ECHO trial
Michael Wang, Professor in the Department of Lymphoma/Myeloma and in the Department of Stem Cell…
May 21, 2024, 12:00 | Blog
Michael Wang: Mechanisms of Senescence‑Associated Drug Resistance in Lymphoma
Michael Wang, Professor in the Department of Lymphoma/Myeloma and the Department of Stem Cell Transplantation and…
Apr 15, 2024, 16:12 | Insight
Michael Wang: Our Phase I TRANSCEND trial demonstrated that Liso-cel results in consistently high objective response rates
Michael Wang, Professor in the Department of Lymphoma/Myeloma and the Department of Stem Cell Transplantation and…
Mar 31, 2024, 23:07 | Blog
Michael Wang: To my philanthropic donors, I am grateful for your support to further our attack on mantle cell lymphoma
Michael Wang, Professor in the Department of Lymphoma and Myeloma at MD Anderson Cancer Center,…
All: 14 Posts: 1 - 100
Special Coverage